Advertisement

Table of Contents

April 01, 1989; Volume 35,Issue 4

You have access
Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
D C Javitt and S R Zukin

Molecular Pharmacology April 1989, 35 (4) 387-393;
You have access
Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
R W Barrett, M E Steffey and C A Wolfram

Molecular Pharmacology April 1989, 35 (4) 394-400;
You have access
In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
A M Szekely, M L Barbaccia, H Alho and E Costa

Molecular Pharmacology April 1989, 35 (4) 401-408;
You have access
Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
S D Shukla, W J Morrison and A Dhar

Molecular Pharmacology April 1989, 35 (4) 409-413;
You have access
Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
R Busche, B Tümmler, J R Riordan and D F Cano-Gauci

Molecular Pharmacology April 1989, 35 (4) 414-421;
You have access
Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
S T Davis and S H Berger

Molecular Pharmacology April 1989, 35 (4) 422-427;
You have access
Transfer RNA is cleaved by activated bleomycin.
R S Magliozzo, J Peisach and M R Ciriolo

Molecular Pharmacology April 1989, 35 (4) 428-432;
You have access
Use of an inducible hybrid viral gene as a model for evaluating drug effects on gene expression.
R P Beckmann and T A Beerman

Molecular Pharmacology April 1989, 35 (4) 433-442;
You have access
Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato

Molecular Pharmacology April 1989, 35 (4) 443-449;
You have access
Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
M Leid, M I Schimerlik and T F Murray

Molecular Pharmacology April 1989, 35 (4) 450-457;
You have access
Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cells.
M A Rogawski

Molecular Pharmacology April 1989, 35 (4) 458-468;
You have access
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
N J Buckley, T I Bonner, C M Buckley and M R Brann

Molecular Pharmacology April 1989, 35 (4) 469-476;
You have access
The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
P Eveleigh, E C Hulme, C Schudt and N J Birdsall

Molecular Pharmacology April 1989, 35 (4) 477-483;
You have access
Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani

Molecular Pharmacology April 1989, 35 (4) 484-494;
You have access
The conformational analysis of delta 9- and delta 9,11-tetrahydrocannabinols in solution using high resolution nuclear magnetic resonance spectroscopy.
R W Kriwacki and A Makriyannis

Molecular Pharmacology April 1989, 35 (4) 495-503;
You have access
In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
S Kubow and P G Wells

Molecular Pharmacology April 1989, 35 (4) 504-511;
You have access
Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
S A Belinsky, F C Kauffman and R G Thurman

Molecular Pharmacology April 1989, 35 (4) 512-518;
You have access
Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
D J Waxman, J J Morrissey and G A Leblanc

Molecular Pharmacology April 1989, 35 (4) 519-525;
You have access
Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes

Molecular Pharmacology April 1989, 35 (4) 526-532;
You have access
Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
W J Phillips and P M Hinkle

Molecular Pharmacology April 1989, 35 (4) 533-540;
You have access
Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
X Y Wei, A Rutledge and D J Triggle

Molecular Pharmacology April 1989, 35 (4) 541-552;